The company is moving from a 900-square-foot space to a 2,800-square-foot space. DiFUSION is working to commercialize its first product line, Xiphos. Its second product, CleanFUZE, is pending FDA approval and could go into clinical studies next year.
CleanFUZE is a spinal implant that time-releases antimicrobial silver ions to prevent infections.
Read the report on DiFusion Technologies.
Related Articles on Orthopedic Device Companies:
14 New Orthopedic and Spine Device Company Financial Reports
Orthopedic Device Company Nomcomed Plans $2.78M Expansion to Indiana Facility
Orthopedic Device Company CEOs Expect Market Growth in 2011
